CVRdatabase
Menu

Zerion Pharma A/S

Public limited companyCVR 40169229København ØActive

Zerion Pharma A/S is a public limited company, based in København Ø, active in manufacture of pharmaceutical preparations, founded in 2019. Equity was negative at the end of 2025 (−DKK 3.5m). The company made a loss in both 2024 and 2025, most recently DKK 10.8m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 3.4m−2.2% vs. 2024
Net profit−DKK 10.8m−4,822.4% vs. 2024
Equity−DKK 3.5m−55.5% vs. 2024
Employees15latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Revenue fell 2% (2024 → 2025), to DKK 3.4m.
  • The loss grew: from DKK 220k to DKK 10.8m (2024 → 2025).

Employees

  • 5 more employees than a year earlier: 15 (07/2026) against 10 (07/2025).

Management and owners, last 24 months

  • New in management: Geelanie Rodriguez Briones (deputy chair, 25/06/2025) and Geelanie Rodriguez Briones (board member, 05/02/2025).
  • Stepped down: Lars Lykke Thomsen (deputy chair, 25/06/2025) and Geelanie Rodriguez Briones (board member, 24/06/2025).
  • New owners registered: Geelanie Rodriguez Briones (05/02/2025).

Registrations, last 24 months

  • 24/06/2026: Share capital changed from 1,076,938 DKK to 1,224,483 DKK
  • 01/04/2026: Share capital changed from 1,024,863 DKK to 1,076,938 DKK
  • 17/02/2025: Share capital changed from 1,024,186 DKK to 1,024,863 DKK
  • 05/02/2025: Share capital changed from 907,265 DKK to 1,024,186 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 18m−DKK 16m−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
EquityNet profit
Financial figures for Zerion Pharma A/S
202020212022202320242025Change
Revenuenot stated1,9333,2733,5603,4523,378−2.2%
Gross profit784−6,715−10,913−5,253−5,834−4,792+17.9%
Operating profit (EBIT)−3,740−13,180−20,892−11,947−13,268−12,404+6.5%
Profit before tax−4,011−13,746−22,129−13,506−2,500−13,137−425.4%
Net profit−3,478−11,134−18,857−11,102−220−10,830−4,822.4%
Total assets7,00013,69812,4238,4729,67111,055+14.3%
Equity−1,029−867−9,958−13,731−2,258−3,511−55.5%
Liabilities8,02914,56422,38122,20311,93014,566+22.1%
Cash and cash equivalents3,9496,6444,1042,3003,4673,633+4.8%
Average number of employees3812111210−16.7%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 3.5m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Zerion Pharma A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202525/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202426/06/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202315/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202229/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202107/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202011/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681012141608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profit−DKK 4.8mNo. 46 of 57
Better than 20% of the companies in the industry
Equity−DKK 3.5mNo. 48 of 59
Better than 19% of the companies in the industry
Number of employees15No. 29 of 59
Better than 52% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bn
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,516of 69,742
Better than 0%
No. 68,872of 69,964
Better than 2%
Same industry and fewer than 20 employees37 companies in the comparison
No. 28of 36
Better than 23%
No. 29of 37
Better than 22%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,430of 33,588
Better than 0%
No. 32,877of 33,687
Better than 2%
All companies of type A/S18,025 companies in the comparison
No. 17,633of 17,786
Better than 1%
No. 17,610of 18,024
Better than 2%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Zerion Pharma A/S−DKK 4.8m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Zerion Pharma A/S−DKK 10.8m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Zerion Pharma A/S−DKK 3.5m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Zerion Pharma A/S15
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Wiborg International Holding ApS5%
  • Waterman ApS5%
  • Running Man ApS5%
  • Bohring ApS5%
  • Mohan.dk ApS5%
  • Geelanie Rodriguez Briones5%
Zerion Pharma A/S

Management

6 active registrations

Executive management

Executive management at Zerion Pharma A/S
NameRoleAppointed
Ole Sylvester-Hvid WiborgDirector14/01/2019

Board of directors

Board of directors at Zerion Pharma A/S
NameRoleAppointed
Jorrit Jeroen WaterBoard member10/10/2019
Dorte Juhl ArnbjergBoard member14/12/2021
Carl-Åke CarlssonChair of the board18/09/2023
Allan StichBoard member28/06/2024
Geelanie Rodriguez BrionesDeputy chair25/06/2025
Founders
Wiborg International Holding ApS
Former management (10)
Former management at Zerion Pharma A/S
NameRoleAppointedResigned
Ole Sylvester-Hvid WiborgBoard member10/10/201927/12/2021
Adam Jun BohrBoard member10/10/201906/05/2021
Peter Mohan ChristiansenChair of the board10/10/201906/05/2021
Christian Bone Falk-RønneBoard member10/10/201906/05/2021
Korbinian Arthur Maria LöbmannDeputy chair10/10/201906/05/2021
Lars Lykke ThomsenBoard member06/05/202113/12/2021
Torsten Rüdiger GoeschBoard member06/05/202111/05/2021
Torsten Rüdiger GoeschChair of the board12/05/202118/09/2023
Lars Lykke ThomsenDeputy chair14/12/202125/06/2025
Geelanie Rodriguez BrionesBoard member05/02/202524/06/2025

Signing rule: Selskabet tegnes af bestyrelsens formand eller næstformand i forening med en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Fruebjergvej 3
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Zerion Pharma A/SFruebjergvej 3, 2100 København Ø121024301385

Purpose

Selskabets formål er at drive virksomhed med udvikling af lægemidler samt enhver i forbindelse hermed stående virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

66 registered events
20263 changesaccounts 1 · capital 2
  • Annual report for 2025 published
  • Share capital changed from 1,076,938 DKK to 1,224,483 DKK
  • Share capital changed from 1,024,863 DKK to 1,076,938 DKK
20258 changesaccounts 1 · management 4 · capital 2 · ownership 1
  • Annual report for 2024 published
  • Geelanie Rodriguez Briones appointed deputy chair
  • Lars Lykke Thomsen stepped down as deputy chair
  • Geelanie Rodriguez Briones stepped down as board member
  • Share capital changed from 1,024,186 DKK to 1,024,863 DKK
  • Share capital changed from 907,265 DKK to 1,024,186 DKK
  • Geelanie Rodriguez Briones appointed board member
  • Geelanie Rodriguez Briones registered as owner (5%)
20246 changescapital 3 · accounts 1 · ownership 1 · management 1
  • Share capital changed from 824,378 DKK to 907,265 DKK
  • Share capital changed from 802,550 DKK to 824,378 DKK
  • Annual report for 2023 published
  • Share capital changed from 640,018 DKK to 802,550 DKK
  • CBFR ApS is no longer registered as owner
  • Allan Stich appointed board member
20236 changesmanagement 2 · accounts 1 · capital 3
  • Carl-Åke Carlsson appointed chair of the board
  • Torsten Rüdiger Goesch stepped down as chair of the board
  • Annual report for 2022 published
  • Share capital changed from 638,259 DKK to 640,018 DKK
  • Share capital changed from 579,159 DKK to 638,259 DKK
  • Share capital changed from 520,927 DKK to 579,159 DKK
20224 changescapital 2 · address 1 · accounts 1
  • Share capital changed from 485,203 DKK to 520,927 DKK
  • Moved to Fruebjergvej 3, 2100 København Ø
  • Annual report for 2021 published
  • Share capital changed from 459,476 DKK to 485,203 DKK
202119 changesmanagement 12 · name 2 · capital 3 · accounts 1 · ownership 1
  • Ole Sylvester-Hvid Wiborg stepped down as board member
  • Name changed from Zerion Pharma ApS to Zerion Pharma A/S
  • Share capital changed from 111,739 DKK to 459,476 DKK
  • Lars Lykke Thomsen appointed deputy chair
  • Dorte Juhl Arnbjerg appointed board member
  • Lars Lykke Thomsen stepped down as board member
  • Torsten Rüdiger Goesch appointed chair of the board
  • Torsten Rüdiger Goesch stepped down as board member
  • Annual report for 2020 published
  • Torsten Rüdiger Goesch appointed board member
  • Lars Lykke Thomsen appointed board member
  • Adam Jun Bohr stepped down as board member
  • Korbinian Arthur Maria Löbmann stepped down as deputy chair
  • Christian Bone Falk-Rønne stepped down as board member
  • Peter Mohan Christiansen stepped down as chair of the board
  • Share capital changed from 103,472 DKK to 111,739 DKK
  • Name changed from Zerion ApS to Zerion Pharma ApS
  • Share capital changed from 102,246 DKK to 103,472 DKK
  • CBFR ApS registered as owner (5%)
20201 changecapital 1
  • Share capital changed from 91,117 DKK to 102,246 DKK
201919 changesmanagement 7 · capital 4 · ownership 7 · founded 1
  • Adam Jun Bohr appointed board member
  • Ole Sylvester-Hvid Wiborg appointed board member
  • Jorrit Jeroen Water appointed board member
  • Korbinian Arthur Maria Löbmann appointed deputy chair
  • Christian Bone Falk-Rønne appointed board member
  • Peter Mohan Christiansen appointed chair of the board
  • Share capital changed from 77,517 DKK to 91,117 DKK
  • Share capital changed from 72,917 DKK to 77,517 DKK
  • Share capital changed from 50,833 DKK to 72,917 DKK
  • Mohan.dk ApS registered as owner (5%)
  • Share capital changed from 50,000 DKK to 50,833 DKK
  • Bohring ApS registered as owner (5%)
  • Running Man ApS registered as owner (5%)
  • WIBORG INTERNATIONAL HOLDING ApS registered as owner (5%)
  • Waterman ApS registered as owner (5%)
  • WIBORG INTERNATIONAL HOLDING ApS is no longer registered as owner
  • Registered as Zerion ApS
  • Ole Sylvester-Hvid Wiborg appointed director
  • WIBORG INTERNATIONAL HOLDING ApS registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction